What question did this study set out to answer?

To explore the association between minimal change disease and neuroblastoma in a pediatric case.

April 23, 2026Open Access

A causal link or coincidence? Anti-nephrin antibody-positive minimal change disease coexisting with neuroblastoma in a child

Key Points

To explore the association between minimal change disease and neuroblastoma in a pediatric case.
Description of clinical symptoms including edema and proteinuria
Chest imaging and PET/CT scan to identify neuroblastoma
Pathological examination post-surgery and kidney biopsy for confirmation of MCD
Nephrotic syndrome persisted despite complete tumor resection
Detection of serum anti-nephrin antibodies confirms diagnosis of MCD
Treatment with glucocorticoids led to significant improvement in symptoms

Abstract

The combination of minimal change disease and solid tumors is uncommon, and its mechanism is often associated with immune disorders or metabolic abnormalities. Here, we describe an 8-year-old girl who presented with nephrotic syndrome characterized by edema and proteinuria as the initial symptoms. Chest imaging incidentally revealed the presence of a chest mass. Subsequently, a PET/CT scan ruled out the possibility of renal infiltration. Following surgical resection of the mass, pathological examination ultimately confirmed it as neuroblastoma. However, even after complete tumor resection, the nephrotic syndrome in the child did not show any relief. A kidney biopsy confirmed minimal change disease, and serum anti-nephrin antibodies were detected. After treatment with glucocorticoids, significant relief of edema, proteinuria, and hypoalbuminemia was observed in the short term. We report a case of newly diagnosed MCD associated with neuroblastoma. This rare case highlights the importance of integrating clinical manifestations, imaging, pathology, and anti-nephrin antibody testing to assist in diagnosis and treatment.

Ask AI

Helpful

Bookmark

View Full Paper